What do we know about pharmacy-based take-home naloxone programs?
Check out our recent scoping review: https://doi.org/10.3390/pharmacy9010030
Who should receive a naloxone kit?Answer: Anyone using opioids or at risk of opioid-induced respiratory depression.
Check out the new Canadian consensus guidelines: https://doi.org/10.1177/1715163520949973
What do we know about the role of PDGF signaling in neurodegenerative disease
Check out our recent review here: https://doi.org/10.20517/2574-1209.2020.16
About
Dr. Michael A. Beazely has been a professor at the School of Pharmacy, University of Waterloo, since it was established in 2008. Our research if focused on the fundamentals of neuronal signaling and substance use education and harm reduction.
Contact
Michael A. Beazely
Associate Professor
School of Pharmacy, University of Waterloo
10 Victoria Street South
Kitchener, ON, N2G 1C5
519.888.4567 x21310